Published in Neurology on May 01, 1992
Recombinant tissue plasminogen activator for acute ischaemic stroke: an updated systematic review and meta-analysis. Lancet (2012) 4.66
Methodology of the Interventional Management of Stroke III Trial. Int J Stroke (2008) 2.88
Recommendations on angiographic revascularization grading standards for acute ischemic stroke: a consensus statement. Stroke (2013) 2.50
Factors affecting the apparent efficacy and safety of tissue plasminogen activator in thrombotic occlusion models of stroke: systematic review and meta-analysis. J Cereb Blood Flow Metab (2010) 1.89
Equipoise among recanalization strategies. Neurology (2010) 1.77
Thrombolysis for acute ischaemic stroke. Cochrane Database Syst Rev (2014) 1.76
Interventional neuroradiology. BMJ (1995) 1.38
Cerebral collateral circulation in carotid artery disease. Curr Cardiol Rev (2009) 0.93
Comparison of susceptibility weighted imaging and TOF-angiography for the detection of Thrombi in acute stroke. PLoS One (2013) 0.93
Thrombolytic Therapy in Acute Ischemic Stroke. Curr Treat Options Cardiovasc Med (2003) 0.90
2C or not 2C: defining an improved revascularization grading scale and the need for standardization of angiography outcomes in stroke trials. J Neurointerv Surg (2013) 0.90
Revascularization grading in endovascular acute ischemic stroke therapy. Neurology (2012) 0.90
Mechanical reperfusion is associated with post-ischemic hemorrhage in rat brain. Exp Neurol (2009) 0.89
Current perspectives on the use of intravenous recombinant tissue plasminogen activator (tPA) for treatment of acute ischemic stroke. Vasc Health Risk Manag (2014) 0.88
Safety and feasibility of intravenous thrombolytic therapy in Iranian patients with acute ischemic stroke. Med J Islam Repub Iran (2013) 0.87
Determinants of outcome in patients eligible for thrombolysis for ischemic stroke. Vasc Health Risk Manag (2007) 0.86
Mechanical Thrombectomy Is Now the Gold Standard for Acute Ischemic Stroke: Implications for Routine Clinical Practice. Interv Neurol (2015) 0.84
Endovascular treatment for acute ischemic stroke patients: implications and interpretation of IMS III, MR RESCUE, and SYNTHESIS EXPANSION trials: A report from the Working Group of International Congress of Interventional Neurology. J Vasc Interv Neurol (2014) 0.84
Observer reliability of CT angiography in the assessment of acute ischaemic stroke: data from the Third International Stroke Trial. Neuroradiology (2014) 0.84
Retrievable stent thrombectomy in the treatment of acute ischemic stroke: analysis of a revolutionizing treatment technique. J Clin Neurosci (2013) 0.82
Clinical relevance and practical implications of trials of perfusion and angiographic imaging in patients with acute ischaemic stroke: a multicentre cohort imaging study. J Neurol Neurosurg Psychiatry (2013) 0.82
Influence of the site of arterial occlusion on multiple baseline hemodynamic MRI parameters and post-thrombolytic recanalization in acute stroke. Neuroradiology (2004) 0.81
Intravenous thrombolytics for ischemic stroke. Neurotherapeutics (2011) 0.81
Imaging of acute stroke prior to treatment: current practice and evolving techniques. Br J Radiol (2014) 0.81
Statistical analysis plan for evaluating low- vs. standard-dose alteplase in the ENhanced Control of Hypertension and Thrombolysis strokE stuDy (ENCHANTED). Int J Stroke (2015) 0.80
Combined neurothrombectomy or thrombolysis with adjunctive delivery of 3K3A-activated protein C in acute ischemic stroke. Front Cell Neurosci (2015) 0.80
CT angiography in an acute stroke protocol: correlation between occlusion site and outcome of intravenous thrombolysis. Interv Neuroradiol (2013) 0.79
Intra-arterial thrombolysis in acute ischaemic stroke: experience with a superselective catheter embedded in the clot. J Neurol Neurosurg Psychiatry (1996) 0.79
Catheter-based interventions for acute ischaemic stroke. Eur Heart J (2015) 0.78
Determinants of early outcomes in patients with acute ischemic stroke and proximal artery occlusion. J Stroke Cerebrovasc Dis (2014) 0.78
Reperfusion therapy of acute ischaemic stroke and acute myocardial infarction: similarities and differences. Eur Heart J (2013) 0.78
Intra-arterial versus intra-venous thrombolysis within and after the first 3 hours of stroke onset. Arch Med Sci (2010) 0.77
Plasminogen activators and ischemic stroke: conditions for acute delivery. Semin Thromb Hemost (2013) 0.77
Endovascular therapy in hyperacute ischaemic stroke: history and current status. Interv Neuroradiol (2013) 0.76
Recanalization therapy for acute ischemic stroke, part 1: surgical embolectomy and chemical thrombolysis. Neurosurg Rev (2010) 0.76
Superselective Intra-arterial Thrombolysis for Acute Cardioembolic Stroke in a Child with Idiopathic Dilated Cardiomyopathy. A Case Report. Interv Neuroradiol (2001) 0.75
Treatment Strategies for Acute Ischemic Stroke Caused by Carotid Artery Occlusion. Interv Neurol (2016) 0.75
Pharmaceutical sponsorship bias influences thrombolytic literature in acute ischemic stroke. West J Emerg Med (2011) 0.75
Formation of a Liquid Jet by Interaction between a Laser-induced Bubble and a Shock Wave. Interv Neuroradiol (2002) 0.75
Assessment of recanalization after intra-arterial thrombolysis in patients with acute ischemic stroke : proposed modification of the qureshi grading system. J Korean Neurosurg Soc (2012) 0.75
The pREset Stent Retriever for Endovascular Treatment of Stroke Caused by MCA Occlusion: Safety and Clinical Outcome. Clin Neuroradiol (2014) 0.75
The need for a population-based, dose optimization study for recombinant tissue plasminogen activator in acute ischemic stroke: A study from a tertiary care teaching hospital from South India. Ann Indian Acad Neurol (2017) 0.75
Evaluation of local intra-arterial fibrinolytic therapy for acute middle cerebral artery occlusion. Interv Neuroradiol (2001) 0.75
Fibrinolysis and Beyond: Bridging the Gap between Local and Systemic Clot Removal. Front Neurol (2011) 0.75
New insight into transient contrast enhancement on computed tomography after endovascular treatment of stroke. Interv Neuroradiol (2012) 0.75
TPA in stroke. Neurology (1993) 0.75
The progress of telestroke in China. Stroke Vasc Neurol (2017) 0.75
Scoring flow restoration in cerebral angiograms after endovascular revascularization in acute ischemic stroke patients. Neuroradiology (2014) 0.75
19th Meeting of the European Neurological Society. Milan, Italy, 5-9 June 1999. Abstracts. J Neurol (1999) 0.75
LC3, a mammalian homologue of yeast Apg8p, is localized in autophagosome membranes after processing. EMBO J (2000) 41.48
Dissection of autophagosome formation using Apg5-deficient mouse embryonic stem cells. J Cell Biol (2001) 13.98
Isolation and characterization of autophagy-defective mutants of Saccharomyces cerevisiae. FEBS Lett (1993) 13.48
A protein conjugation system essential for autophagy. Nature (1998) 12.71
Tor, a phosphatidylinositol kinase homologue, controls autophagy in yeast. J Biol Chem (1998) 10.77
A ubiquitin-like system mediates protein lipidation. Nature (2000) 10.61
Tor-mediated induction of autophagy via an Apg1 protein kinase complex. J Cell Biol (2000) 9.61
Formation process of autophagosome is traced with Apg8/Aut7p in yeast. J Cell Biol (1999) 9.33
The pre-autophagosomal structure organized by concerted functions of APG genes is essential for autophagosome formation. EMBO J (2001) 8.84
Autophagy in yeast demonstrated with proteinase-deficient mutants and conditions for its induction. J Cell Biol (1992) 8.33
Vacuolar import of proteins and organelles from the cytoplasm. Annu Rev Cell Dev Biol (1999) 7.75
Two distinct Vps34 phosphatidylinositol 3-kinase complexes function in autophagy and carboxypeptidase Y sorting in Saccharomyces cerevisiae. J Cell Biol (2001) 7.68
The reversible modification regulates the membrane-binding state of Apg8/Aut7 essential for autophagy and the cytoplasm to vacuole targeting pathway. J Cell Biol (2000) 7.48
Beclin-phosphatidylinositol 3-kinase complex functions at the trans-Golgi network. EMBO Rep (2001) 7.13
Leptomycin B inhibition of signal-mediated nuclear export by direct binding to CRM1. Exp Cell Res (1998) 6.11
Novel system for monitoring autophagy in the yeast Saccharomyces cerevisiae. Biochem Biophys Res Commun (1995) 5.89
A compendium of gene expression in normal human tissues. Physiol Genomics (2001) 5.66
Two distinct pathways for targeting proteins from the cytoplasm to the vacuole/lysosome. J Cell Biol (1997) 5.57
Apg1p, a novel protein kinase required for the autophagic process in Saccharomyces cerevisiae. Gene (1997) 5.53
Ultrastructural analysis of the autophagic process in yeast: detection of autophagosomes and their characterization. J Cell Biol (1994) 5.41
A new protein conjugation system in human. The counterpart of the yeast Apg12p conjugation system essential for autophagy. J Biol Chem (1998) 5.07
Cytoplasm-to-vacuole targeting and autophagy employ the same machinery to deliver proteins to the yeast vacuole. Proc Natl Acad Sci U S A (1996) 4.97
Apg7p/Cvt2p: A novel protein-activating enzyme essential for autophagy. Mol Biol Cell (1999) 4.68
Targeted disruption of the NF-IL6 gene discloses its essential role in bacteria killing and tumor cytotoxicity by macrophages. Cell (1995) 4.34
Apg9p/Cvt7p is an integral membrane protein required for transport vesicle formation in the Cvt and autophagy pathways. J Cell Biol (2000) 4.30
Cvt9/Gsa9 functions in sequestering selective cytosolic cargo destined for the vacuole. J Cell Biol (2001) 4.25
The mouse SKD1, a homologue of yeast Vps4p, is required for normal endosomal trafficking and morphology in mammalian cells. Mol Biol Cell (2000) 4.22
Apg16p is required for the function of the Apg12p-Apg5p conjugate in the yeast autophagy pathway. EMBO J (1999) 3.97
Apg14p and Apg6/Vps30p form a protein complex essential for autophagy in the yeast, Saccharomyces cerevisiae. J Biol Chem (1998) 3.93
Analyses of APG13 gene involved in autophagy in yeast, Saccharomyces cerevisiae. Gene (1997) 3.88
Aminopeptidase I is targeted to the vacuole by a nonclassical vesicular mechanism. J Cell Biol (1997) 3.81
Transcriptional sequencing: A method for DNA sequencing using RNA polymerase. Proc Natl Acad Sci U S A (1998) 3.78
Apg10p, a novel protein-conjugating enzyme essential for autophagy in yeast. EMBO J (1999) 3.70
Effect of matching of class I HLA alleles on clinical outcome after transplantation of hematopoietic stem cells from an unrelated donor. Japan Marrow Donor Program. N Engl J Med (1998) 3.62
Acinus is a caspase-3-activated protein required for apoptotic chromatin condensation. Nature (1999) 3.43
Autophagosome requires specific early Sec proteins for its formation and NSF/SNARE for vacuolar fusion. Mol Biol Cell (2001) 3.41
A formalin-inactivated whole SIV vaccine confers protection in macaques. Science (1989) 3.37
Apg13p and Vac8p are part of a complex of phosphoproteins that are required for cytoplasm to vacuole targeting. J Biol Chem (2000) 3.25
Production of low-affinity penicillin-binding protein by low- and high-resistance groups of methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother (1987) 3.07
CIS3/SOCS3/SSI3 plays a negative regulatory role in STAT3 activation and intestinal inflammation. J Exp Med (2001) 3.05
cDNA sequence of human transforming gene hst and identification of the coding sequence required for transforming activity. Proc Natl Acad Sci U S A (1987) 2.97
Presynaptic inhibition caused by retrograde signal from metabotropic glutamate to cannabinoid receptors. Neuron (2001) 2.94
The neural RNA-binding protein Musashi1 translationally regulates mammalian numb gene expression by interacting with its mRNA. Mol Cell Biol (2001) 2.87
The production of migration inhibition factor by B and T cells of the guinea pig. J Exp Med (1973) 2.86
Sulfazecin and isosulfazecin, novel beta-lactam antibiotics of bacterial origin. Nature (1981) 2.84
Gemcitabine alone or in combination with cisplatin in patients with biliary tract cancer: a comparative multicentre study in Japan. Br J Cancer (2010) 2.82
Properties of H+-translocating adenosine triphosphatase in vacuolar membranes of SAccharomyces cerevisiae. J Biol Chem (1981) 2.81
Extracellular signal-dependent nuclear import of Stat1 is mediated by nuclear pore-targeting complex formation with NPI-1, but not Rch1. EMBO J (1997) 2.80
Pleiotropic phenomena in autolytic enzyme(s) content, flagellation, and simultaneous hyperproduction of extracellular alpha-amylase and protease in a Bacillus subtilis mutant. J Bacteriol (1975) 2.78
Brain dynein (MAP1C) localizes on both anterogradely and retrogradely transported membranous organelles in vivo. J Cell Biol (1990) 2.76
In vivo evidence for involvement of a 58 kDa component of nuclear pore-targeting complex in nuclear protein import. EMBO J (1995) 2.74
A Flavobacterium sp. that degrades diazinon and parathion. Can J Microbiol (1973) 2.72
The paramyxovirus, Sendai virus, V protein encodes a luxury function required for viral pathogenesis. EMBO J (1997) 2.71
Targeted disruption of gp130, a common signal transducer for the interleukin 6 family of cytokines, leads to myocardial and hematological disorders. Proc Natl Acad Sci U S A (1996) 2.70
Analysis of the membrane structures involved in autophagy in yeast by freeze-replica method. Cell Struct Funct (1995) 2.69
Calcium transport driven by a proton motive force in vacuolar membrane vesicles of Saccharomyces cerevisiae. J Biol Chem (1983) 2.62
Microsatellite instability and mutation of mitochondrial and nuclear DNA in gastric carcinoma. Gastroenterology (2000) 2.61
Moxalactam (6059-S), a novel 1-oxa-beta-lactam with an expanded antibacterial spectrum: laboratory evaluation. Antimicrob Agents Chemother (1980) 2.59
Purification and properties of H+-translocating, Mg2+-adenosine triphosphatase from vacuolar membranes of Saccharomyces cerevisiae. J Biol Chem (1985) 2.54
Transcriptive complex of Newcastle disease virus. I. Both L and P proteins are required to constitute an active complex. Virology (1983) 2.53
Absence of tumor necrosis factor rescues RelA-deficient mice from embryonic lethality. Proc Natl Acad Sci U S A (1999) 2.53
Active transport of basic amino acids driven by a proton motive force in vacuolar membrane vesicles of Saccharomyces cerevisiae. J Biol Chem (1981) 2.51
Molecular analysis of the Escherichia coli hns gene encoding a DNA-binding protein, which preferentially recognizes curved DNA sequences. Mol Gen Genet (1991) 2.50
Determination of antibody-hapten equilibrium constants by an ammonium sulfate precipitation technique. J Immunol (1969) 2.49
Genes for directing vacuolar morphogenesis in Saccharomyces cerevisiae. I. Isolation and characterization of two classes of vam mutants. J Biol Chem (1992) 2.45
Decision latitude, job strain, and myocardial infarction: a study of working men in Stockholm. The SHEEP Study Group. Stockholm Heart epidemiology Program. Am J Public Health (1998) 2.40
Apg5p functions in the sequestration step in the cytoplasm-to-vacuole targeting and macroautophagy pathways. Mol Biol Cell (2000) 2.33
Autophagy in yeast: a TOR-mediated response to nutrient starvation. Curr Top Microbiol Immunol (2004) 2.27
Triggering of autolytic cell wall degradation in Escherichia coli by beta-lactam antibiotics. Antimicrob Agents Chemother (1979) 2.26
A familial factor XIII subunit B deficiency. Br J Haematol (1990) 2.23
Ran-unassisted nuclear migration of a 97-kD component of nuclear pore-targeting complex. J Cell Biol (1997) 2.18
Cloning and expression of cDNA for rat heme oxygenase. Proc Natl Acad Sci U S A (1985) 2.18
Disruption of the Bcl6 gene results in an impaired germinal center formation. J Exp Med (1997) 2.17
Comparison of whole genome sequences of Chlamydia pneumoniae J138 from Japan and CWL029 from USA. Nucleic Acids Res (2000) 2.16
Induction of the cytokine signal regulator SOCS3/CIS3 as a therapeutic strategy for treating inflammatory arthritis. J Clin Invest (2001) 2.15
A karyophilic protein forms a stable complex with cytoplasmic components prior to nuclear pore binding. J Biol Chem (1995) 2.12
The nuclear pore-targeting complex binds to nuclear pores after association with a karyophile. FEBS Lett (1995) 2.10
In vitro and in vivo antibacterial activities of ME1207, a new oral cephalosporin. Antimicrob Agents Chemother (1988) 2.08
Rho-kinase/ROCK is involved in cytokinesis through the phosphorylation of myosin light chain and not ezrin/radixin/moesin proteins at the cleavage furrow. Oncogene (2000) 2.08
Structural and functional analyses of APG5, a gene involved in autophagy in yeast. Gene (1996) 2.06
Vam3p, a new member of syntaxin related protein, is required for vacuolar assembly in the yeast Saccharomyces cerevisiae. J Cell Sci (1997) 2.05
Nucleotide sequence of the Serratia marcescens SR50 chromosomal ampC beta-lactamase gene. FEMS Microbiol Lett (1990) 2.04
Acute renal failure associated with spontaneous perinephric hemorrhage. Nephron (2000) 2.02
Nucleotide sequence of the CLS4 (CDC24) gene of Saccharomyces cerevisiae. Gene (1987) 2.00
Genetic alterations of the c-erbB-2 oncogene occur frequently in tubular adenocarcinoma of the stomach and are often accompanied by amplification of the v-erbA homologue. Oncogene (1988) 1.99
K-sam, an amplified gene in stomach cancer, is a member of the heparin-binding growth factor receptor genes. Proc Natl Acad Sci U S A (1990) 1.99
Unique cholesteryl glucosides in Helicobacter pylori: composition and structural analysis. J Bacteriol (1995) 1.97
Vam2/Vps41p and Vam6/Vps39p are components of a protein complex on the vacuolar membranes and involved in the vacuolar assembly in the yeast Saccharomyces cerevisiae. J Biol Chem (1997) 1.97
Molecular cloning and cell cycle-dependent expression of mammalian CRM1, a protein involved in nuclear export of proteins. J Biol Chem (1997) 1.96
Two distinct mechanisms cause heterogeneity of 16S rRNA. J Bacteriol (1999) 1.94
Live fluorescence imaging reveals early recruitment of emerin, LBR, RanBP2, and Nup153 to reforming functional nuclear envelopes. J Cell Sci (2000) 1.93
Mutation of Bacillus subtilis causing hyperproduction of alpha-amylase and protease, and its synergistic effect. J Bacteriol (1975) 1.88
Calcium-sensitive cls4 mutant of Saccharomyces cerevisiae with a defect in bud formation. J Bacteriol (1986) 1.87
Three-dimensional analysis of morphogenesis induced by mating pheromone alpha factor in Saccharomyces cerevisiae. J Cell Sci (1989) 1.85
Apg2p functions in autophagosome formation on the perivacuolar structure. J Biol Chem (2001) 1.82
A protein conjugation system in yeast with homology to biosynthetic enzyme reaction of prokaryotes. J Biol Chem (2000) 1.82
Substrate specificities of active transport systems for amino acids in vacuolar-membrane vesicles of Saccharomyces cerevisiae. Evidence of seven independent proton/amino acid antiport systems. J Biol Chem (1984) 1.82
Membrane (M) protein of HVJ (Sendai virus): its role in virus assembly. Virology (1976) 1.81
Crystal structure of rat biliverdin reductase. Nat Struct Biol (2001) 1.77